Search - tctmd.com

Displaying 1 - 20 of 398

Sort: Relevancy | Date

Top Structural Heart News of 2024

News Daily News

Top Structural Heart News of 2024

December 29, 2024

Radial Artery Best for Secondary Access During TAVI: PULSE Registry

News Daily News

Radial Artery Best for Secondary Access During TAVI: PULSE Registry

Michael O'Riordan

December 23, 2024

Downsizing, Underexpansion Common in Redo TAVI With Sapien 3

News Daily News

Downsizing, Underexpansion Common in Redo TAVI With Sapien 3

December 20, 2024

December 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

December 20, 2024

Reimbursement Issues Seem to Be Holding Renal Denervation Back

News Features

Reimbursement Issues Seem to Be Holding Renal Denervation Back

December 19, 2024

More Surgical Team Familiarity Could Trim Cardiopulmonary Bypass Time

News Daily News

More Surgical Team Familiarity Could Trim Cardiopulmonary Bypass Time

Yael L. Maxwell

December 18, 2024

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

News Conference News PCR London Valves 2024

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

Michael O'Riordan

December 03, 2024

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

News Conference News PCR London Valves 2024

Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years

Michael O'Riordan

November 27, 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

News Conference News PCR London Valves 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presentation AHA 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presenter: Chisato Izumi

November 17, 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

News Conference News AHA 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Michael O'Riordan

November 17, 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

November 01, 2024

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

News Conference News TCT 2024

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

October 31, 2024

Presentation TCT 2024

TCT 796: Association Between Social Determinants of Health and Aortic Valve Replacement in a Large Community-based Health Care System

Presenter: Daniel Spoon

October 30, 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

Patient Considerations

Presentation TCT 2024

Patient Considerations

Presenter: Firas Zahr

October 30, 2024

Imaging Considerations

Presentation TCT 2024

Imaging Considerations

Presenter: Rebecca Hahn

October 30, 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

October 30, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.